Upstream Bio, Inc. (UPB)
9.13
+0.04
(+0.44%)
USD |
NASDAQ |
May 11, 16:00
9.13
0.00 (0.00%)
After-Hours: 20:00
Upstream Bio Shareholders Equity (Quarterly) : 339.77M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amgen, Inc. | 9.19B |
| Regeneron Pharmaceuticals, Inc. | 31.42B |
| Janux Therapeutics, Inc. | 941.54M |
| Evommune, Inc. | 304.56M |
| ACADIA Pharmaceuticals, Inc. | 1.248B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 353.77M |
| Total Liabilities (Quarterly) | 14.00M |
| Debt to Equity Ratio | 0.0037 |
| Current Ratio | 26.15 |
| Net Debt Paydown Yield | 0.01% |